Skip to content

Spontaneous Hemoperitoneum in Pregnancy (SHiP) and Endometriosis – Impact on Quality of Life and Illness Perception

Spontaneous Hemoperitoneum in Pregnancy (SHiP) and Endometriosis – Impact on Quality of Life and Illness Perception

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21857
Enrollment
11
Registered
2016-06-10
Start date
2016-06-08
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, SHiP, hemoperitoneum, pregnancy

Interventions

Questionnaires (SF-36, SVL, UCL, PRISM-RII) and an individual face-to-face in-depth interview will be carried out.

Sponsors

VU University Medical Center Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eleven women with SHiP in their obstetrical history, who already gave written permission to include their case in our previous case-series, will be asked to participate in this trial. Partners will be asked separately if they are willing to participate.

Exclusion criteria

Exclusion criteria: If women or their partners are unable or unwilling to give informed consent, they will be excluded from participation in this trial.

Design outcomes

Primary

MeasureTime frame
The aim of this study is to gain better insight in the psychological and functional recovery of women, and their partners, after SHIP.

Secondary

MeasureTime frame
This study will further assess personality characteristics, illness perception, coping strategies and QOL of women, and their partners, after SHIP.

Contacts

Public ContactMarit Lier

VU Medical Centre Boelelaan 1118

ma.lier@vumc.nl020 4445278

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)